• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

失代偿期肝硬化患者血浆去甲肾上腺素浓度升高。与分泌率增加、清除率正常及中心血容量扩张可抑制性有关。

Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion.

作者信息

Nicholls K M, Shapiro M D, Van Putten V J, Kluge R, Chung H M, Bichet D G, Schrier R W

出版信息

Circ Res. 1985 Mar;56(3):457-61. doi: 10.1161/01.res.56.3.457.

DOI:10.1161/01.res.56.3.457
PMID:3971517
Abstract

Plasma norepinephrine concentrations are elevated in patients with decompensated cirrhosis, and correlate inversely with urinary sodium and water excretion. Increased plasma norepinephrine concentrations may result from a decreased metabolic clearance rate or an increased secretion rate, possibly in response to a decreased "effective arterial blood volume." If the latter hypothesis is correct, plasma norepinephrine might be expected to be suppressed when central blood volume is expanded by head-out water immersion. In the present study, plasma norepinephrine secretion and clearance rates were determined by infusion of tritiated norepinephrine. Norepinephrine secretion rates were elevated in eight cirrhotic patients as compared to control subjects (1.50 +/- 0.25 vs. 0.26 +/- 0.08 micrograms/m2 per min, P less than 0.001), whereas clearance rates were similar (3.13 +/- 0.48 vs. 2.60 +/- 0.28 liters/min, NS). Baseline plasma norepinephrine concentrations were markedly elevated in the cirrhotic patients (830 +/- 136 vs. 185 +/- 12 pg/ml, P less than 0.001). Head-out water immersion significantly suppressed plasma concentrations of both norepinephrine (704 +/- 72 to 475 +/- 70 pg/ml, P less than 0.005) and epinephrine (121 +/- 33 to 57 +/- 10 pg/ml, P less than 0.05) in all seven patients studied. We conclude that the high circulating catecholamine concentrations in cirrhosis are secondary to increased secretion, rather than to decreased metabolic clearance, and are suppressible by central blood volume expansion.

摘要

失代偿期肝硬化患者血浆去甲肾上腺素浓度升高,且与尿钠及水排泄呈负相关。血浆去甲肾上腺素浓度升高可能是由于代谢清除率降低或分泌率增加,这可能是对“有效动脉血容量”减少的一种反应。如果后一种假说是正确的,那么当通过头低位浸水使中心血容量增加时,血浆去甲肾上腺素可能会受到抑制。在本研究中,通过输注氚标记的去甲肾上腺素来测定血浆去甲肾上腺素的分泌和清除率。与对照组相比,8例肝硬化患者的去甲肾上腺素分泌率升高(分别为1.50±0.25与0.26±0.08微克/平方米每分钟,P<0.001),而清除率相似(分别为3.13±0.48与2.60±0.28升/分钟,无显著性差异)。肝硬化患者的基线血浆去甲肾上腺素浓度显著升高(分别为830±136与185±12皮克/毫升,P<0.001)。在所有7例接受研究的患者中,头低位浸水显著抑制了去甲肾上腺素(从704±72降至475±70皮克/毫升,P<0.005)和肾上腺素(从121±33降至57±10皮克/毫升,P<0.05)的血浆浓度。我们得出结论,肝硬化时循环中儿茶酚胺浓度升高是由于分泌增加,而非代谢清除率降低,并且可被中心血容量增加所抑制。

相似文献

1
Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion.失代偿期肝硬化患者血浆去甲肾上腺素浓度升高。与分泌率增加、清除率正常及中心血容量扩张可抑制性有关。
Circ Res. 1985 Mar;56(3):457-61. doi: 10.1161/01.res.56.3.457.
2
Sodium excretion in advanced cirrhosis: effect of expansion of central blood volume and suppression of plasma aldosterone.
Hepatology. 1986 Mar-Apr;6(2):235-8. doi: 10.1002/hep.1840060213.
3
Catecholamine responses to central volume expansion produced by head-out water immersion and saline infusion.
J Clin Endocrinol Metab. 1983 May;56(5):998-1002. doi: 10.1210/jcem-56-5-998.
4
Tyrosine loading in patients with hepatic cirrhosis: lack of effect on plasma catecholamines.
Klin Wochenschr. 1986 Dec 1;64(23):1224-8. doi: 10.1007/BF01734462.
5
Elevated plasma noradrenaline concentrations in patients with low-output cardiac failure: dependence on increased noradrenaline secretion rates.低输出量心力衰竭患者血浆去甲肾上腺素浓度升高:依赖于去甲肾上腺素分泌率增加。
Clin Sci (Lond). 1990 Nov;79(5):429-35. doi: 10.1042/cs0790429.
6
Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.肝硬化难治性腹水:容量扩张和血浆心钠素水平升高的作用
Hepatology. 1993 Sep;18(3):519-28.
7
Mechanisms of improvement of water and sodium excretion by immersion in decompensated cirrhotic patients.失代偿期肝硬化患者浸泡促进水钠排泄的机制
Kidney Int. 1983 Dec;24(6):788-94. doi: 10.1038/ki.1983.229.
8
Effects of water immersion on plasma catecholamines in decompensated cirrhosis. Implications for deranged sodium and water homeostasis.
Miner Electrolyte Metab. 1985;11(1):25-34.
9
Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.增强型体外反搏:一种改善肝硬化患者肾功能的新技术。
Nephrol Dial Transplant. 2005 May;20(5):920-6. doi: 10.1093/ndt/gfh755. Epub 2005 Mar 23.
10
Factors determining renal response to water immersion in non-excretor cirrhotic patients.非排泄型肝硬化患者肾脏对水浸反应的决定因素。
Kidney Int. 1986 Sep;30(3):417-21. doi: 10.1038/ki.1986.200.

引用本文的文献

1
The Effects of SGLT2 Inhibitors on Liver Cirrhosis Patients with Refractory Ascites: A Literature Review.钠-葡萄糖协同转运蛋白2抑制剂对肝硬化难治性腹水患者的影响:文献综述
J Clin Med. 2023 Mar 14;12(6):2253. doi: 10.3390/jcm12062253.
2
Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?肝硬化患者使用β受体阻滞剂:务实还是求全?
Front Med (Lausanne). 2023 Jan 9;9:1100966. doi: 10.3389/fmed.2022.1100966. eCollection 2022.
3
Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review.
腹腔穿刺术诱发循环功能障碍的病理生理学与预防:简要综述
J Clin Transl Hepatol. 2020 Mar 28;8(1):42-48. doi: 10.14218/JCTH.2019.00048. Epub 2020 Mar 26.
4
Differential Sympathetic Vasomotor Activation Induced by Liver Cirrhosis in Rats.肝硬化大鼠中由肝硬化诱导的差异性交感血管舒缩激活
PLoS One. 2016 Apr 7;11(4):e0152512. doi: 10.1371/journal.pone.0152512. eCollection 2016.
5
The Relationship between Renal Dysfunction and Abnormalities of the Immune System in Patients with Decompensated Cirrhosis.失代偿期肝硬化患者肾功能不全与免疫系统异常的关系
ISRN Gastroenterol. 2012;2012:123826. doi: 10.5402/2012/123826. Epub 2012 Dec 26.
6
Physiopathology of splanchnic vasodilation in portal hypertension.门静脉高压症内脏血管扩张的病理生理学
World J Hepatol. 2010 Jun 27;2(6):208-20. doi: 10.4254/wjh.v2.i6.208.
7
Vasopressin deficiency and vasodilatory state in end-stage liver disease.终末期肝病中的血管加压素缺乏和血管扩张状态。
J Cardiothorac Vasc Anesth. 2011 Aug;25(4):665-70. doi: 10.1053/j.jvca.2010.09.018. Epub 2010 Dec 3.
8
Towards goal-directed therapy of hepatorenal syndrome: we have the tools but we need the trials.迈向肝肾综合征的目标导向治疗:我们有工具,但我们需要试验。
Crit Care. 2008;12(2):119. doi: 10.1186/cc6804. Epub 2008 Mar 19.
9
[Sympathetic overactivity and the kidney].
Wien Klin Wochenschr. 2003 Sep 30;115(17-18):634-40. doi: 10.1007/BF03040468.
10
Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation.晚期肝硬化患者对外源性内皮素-1的血管反应改变,肝移植成功后正常血管收缩反应得以恢复的证据。
Gut. 2003 Oct;52(10):1505-10. doi: 10.1136/gut.52.10.1505.